School of Medicine, James Cook University, Queensland, Australia.
BMC Med Genet. 2010 Feb 16;11:26. doi: 10.1186/1471-2350-11-26.
Complete and partial trisomy 9 is the fourth most common chromosomal disorder. It is also associated with various congenital characteristics affecting the cranio-facial, skeletal, central nervous, gastrointestinal, cardiac and renal systems. Very few cases have been reported in adults. Partial trisomy 9q is also associated with short stature, poor growth and growth hormone deficiency. This is the first reported case of an extensive endocrinology investigation of short stature in trisomy 9q and the outcome of growth hormone treatment.
The case involves a 23-year-old female of pure partial trisomy 9q. The case involves a 23-year old female with pure partial trisomy 9q involving a duplication of 9q22.1 to q32, de novo, confirmed by genetic studies using fluorescene in situ hybridization (FISH) method. The diagnosis was at 6 years of age. She did not demonstrate all the congenital morphologies identified with trisomy 9q disorders especially in relation to multi-organ morphologies. There is also a degree of associated intellectual impairment. At prepuberty, she was referred for poor growth and was diagnosed with partial growth hormone deficiency. She responded very well to treatment with growth hormone and is currently living an independent life with some support.
Trisomy 9q is associated with short stature and failure to thrive. Growth hormone deficiency should be identified in cases of trisomy 9q and treatment offered. This is the first reported case of response to growth hormone replacement in partial trisomy 9.
完全和部分 9 号染色体三体是第四种最常见的染色体疾病。它还与各种影响头面部、骨骼、中枢神经系统、胃肠道、心脏和肾脏系统的先天性特征有关。在成人中,非常少的病例被报道。部分 9q 三体还与身材矮小、生长不良和生长激素缺乏有关。这是首例报道的 9q 三体综合征广泛内分泌学调查矮小症的病例,以及生长激素治疗的结果。
该病例涉及一名纯部分 9q 三体的 23 岁女性。该病例涉及一名 23 岁女性,存在纯部分 9q 三体,涉及 9q22.1 至 q32 的重复,是新生的,通过使用荧光原位杂交(FISH)方法的遗传学研究得到证实。诊断是在 6 岁时做出的。她没有表现出与 9q 三体障碍相关的所有先天性形态,特别是在涉及多器官形态方面。也存在一定程度的智力障碍。在青春期前,她因生长不良而被转介,被诊断为部分生长激素缺乏症。她对生长激素治疗反应非常好,目前过着独立生活,有一定的支持。
9q 三体与身材矮小和生长不良有关。如果存在 9q 三体,应确定生长激素缺乏症,并提供治疗。这是首例报道的部分 9 三体对生长激素替代治疗有反应的病例。